insights_auto
Why is HNSA down 2,78%?
Dive Deeperchevron_right
HNSA:STO
Hansa Biopharma AB
SEK 48,18
arrow_downward
-2,78%(-1,38) 1D
17 ພ.ຈ., 17 ໂມງ 29 ນາທີ 39 ວິນາທີ GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HNSA...
Open
SEK 49,26
High
SEK 49,76
Low
SEK 47,50
Mkt. cap
4,90 ຕື້
Avg. vol.
712,68 ພັນ
Volume
1,15 ລ້ານ
52-wk high
SEK 51,65
52-wk low
SEK 23,52
EPS
SEK-7,91
Shares outstanding
101,76 ລ້ານ
No. of employees
111
Open
SEK 49,26
High
SEK 49,76
Low
SEK 47,50
Mkt. cap
4,90 ຕື້
Avg. vol.
712,68 ພັນ
Volume
1,15 ລ້ານ
52-wk high
SEK 51,65
52-wk low
SEK 23,52
EPS
SEK-7,91
Shares outstanding
101,76 ລ້ານ
No. of employees
111
News stories
From web sources and news partners
Investing.com UK
·
7 ຊົ່ວໂມງກ່ອນ
Hansa Biopharma at Jefferies: transplant drug nears key U.S. test By Investing.com
About Hansa Biopharma AB
CEOSøren Tulstrup
Employees111
Founded2007
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitehansabiopharma.com